Simultaneous occurrence of cutaneous mastocytosis and juvenile xanthogranuloma in a child: Random or true association?


Journal

Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 03 02 2020
revised: 17 03 2020
accepted: 05 04 2020
pubmed: 7 5 2020
medline: 15 5 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

Juvenile xanthogranuloma (JXG) and cutaneous mastocytosis (CM) are two distinct conditions that have rarely been reported in association. We report a child with CM and disseminated JXG, who showed a significant decrease in serum tryptase levels and regression of JXG lesions over time. Due to the paucity of reports, a true association between these two conditions has not been validated, although a potential induction of histiocytic lesions by mast cell degranulation has been proposed.

Identifiants

pubmed: 32372415
doi: 10.1111/pde.14185
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

716-720

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Hartmann K, Escribano L, Grattan C et al Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol. 2016;137(1):35-45.
Gruber R, Vassilaki I, Zelger B. Concomitant juvenile xanthogranuloma and cutaneous mastocytosis in a 3-year-old Swedish girl: case report and review of the literature. Int J Dermatol. 2011;50(5):611-614.
Höck M, Zelger B, Schweigmann G et al The various clinical spectra of juvenile xanthogranuloma: imaging for two case reports and review of the literature. BMC Pediatr. 2019;19(1):128.
De Villez RL, Limmer BL. Juvenile xanthogranuloma and urticaria pigmentosa. Arch Dermatol. 1975;111(3):365-366.
Mann RE, Friedman KJ, Milgraum SS. Urticaria pigmentosa and juvenile xanthogranuloma: case report and brief review of the literature. Pediatr Dermatol. 1996;13(2):122-126.
Tsutsui K, Asai Y, Kawashima Y. Urticaria pigmentosa occurring with juvenile xanthogranuloma. Br J Dermatol. 1999;140(5):990-991.
Valent P, Escribano L, Broesby-Olsen S et al Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis. Allergy. 2014;69(10):1267-1274.
Djougarian A, Kodsi S, Naysan J, Kristal L, Marr B. Presumed ocular juvenile xanthogranuloma and biopsy-proven cutaneous mastocytosis occurring sequentially in a young boy. J Pediatr Ophthalmol Strabismus. 2014;51:e89-91.
Bork K. Hereditary progressive mucinous histiocytosis. Immunohistochemical and ultrastructural studies in an additional family. Arch Dermatol. 1994;130(10):1300-1304.
Revert A, Jordá E, Ramón D, Verdeguer JM, Torres V, Pitarch A. Xanthelasmoid mastocytosis. Pediatr Dermatol. 1991;8(2):152-154.
Husak R, Blume-Peytavi U, Pfrommer C, Geilen CC, Goerdt S, Orfanos CE. Nodular and bullous cutaneous mastocytosis of the xanthelasmoid type: case report. Br J Dermatol. 2001;144(2):355-358.
Pérez-Pérez L, Allegue F, Caeiro JL, Fabeiro JM, Pérez Rodríguez A, Zulaica A. Coexistence of two types of clinical lesions in childhood-onset mastocytosis. Indian J Dermatol Venereol Leprol. 2011;77(2):184-187.
Matito A, Azaña JM, Torrelo A, Alvarez-Twose I. Cutaneous mastocytosis in adults and children: new classification and prognostic ractors. Immunol Allergy Clin North Am. 2018;38(3):351-363.
Tran DT, Jokinen CH, Argenyi ZB. Histiocyte-rich pleomorphic mastocytoma: an uncommon variant mimicking juvenile xanthogranuloma and Langerhans cell histiocytosis. J Cutan Pathol. 2009;36(11):1215-1220.
Sueki H, Whitaker D, Buchsbaum M, Murphy GF. Novel interactions between dermal dendrocytes and mast cells in human skin. Implications for hemostasis and matrix repair. Lab Investig J Tech Methods Pathol. 1993;69(2):160-172.

Auteurs

Laura Vergara-de-la-Campa (L)

Department of Dermatology, Complejo Hospitalario de Toledo, Toledo, Spain.

Antonio Torrelo (A)

Department of Dermatology, Hospital Infantil Universitario del Niño Jesús, Spanish Network on Mastocytois (REMA), Madrid, Spain.

Ana Isabel Sánchez-Moya (A)

Department of Dermatology, Complejo Hospitalario de Toledo, Toledo, Spain.

María Recuero-Pradillo (M)

Department of Pathology, Complejo Hospitalario de Toledo, Toledo, Spain.

Manuela Mollejo (M)

Department of Pathology, Complejo Hospitalario de Toledo, Toledo, Spain.

Almudena Matito (A)

Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Spanish Network on Mastocytosis (REMA), Toledo, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH